Works in PharmacoEconomics - Open, 2025, Vol 9, Issue 4


Results: 14
    1
    2
    3

    Assessing the Value for Money of Enzyme Replacement Therapy in Gaucher Disease Types 1 and 3b: Can Expanded Coverage Be Justified?

    Published in:
    PharmacoEconomics - Open, 2025, v. 9, n. 4, p. 611, doi. 10.1007/s41669-025-00579-x
    By:
    • Rattanavipapong, Waranya;
    • Anothaisintawee, Thunyarat;
    • Isaranuwatchai, Wanrudee;
    • Wattanasirichaigoon, Duangrurdee;
    • Tim-Aroon, Thipwimol;
    • Wichajarn, Khunton;
    • Sathienkijkanchai, Achara;
    • Charoenkwan, Pimlak;
    • Suphapeetiporn, Kanya;
    • Traivaree, Chanchai;
    • Kuptanon, Chulaluck;
    • Teerawattananon, Yot
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11

    Cost–Benefit Analysis of the Enhancing Men's Awareness of Testicular diseases (E-MAT) Feasibility Trial: A Virtual Reality Experience to Increase Testicular Knowledge and Self-Examination among Male Athletes.

    Published in:
    PharmacoEconomics - Open, 2025, v. 9, n. 4, p. 671, doi. 10.1007/s41669-025-00571-5
    By:
    • Murphy, Aileen;
    • Kirby, Ann;
    • De Blasio, Federica;
    • McCarthy, Megan;
    • Shiely, Frances;
    • Hegarty, Josephine;
    • Davoren, Martin P.;
    • Harrington, Janas M.;
    • Shorter, Gillian W.;
    • Murphy, David;
    • O'Mahony, Billy;
    • Cooke, Eoghan;
    • Rovito, Michael J.;
    • Robertson, Steve;
    • FitzGerald, Serena;
    • Connor, Alan O.;
    • Riordan, Mícheál O.;
    • Saab, Mohamad M.
    Publication type:
    Article
    12
    13
    14